Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

138.55
-1.2200-0.87%
Post-market: 138.590.0400+0.03%19:44 EDT
Volume:3.43M
Turnover:475.85M
Market Cap:171.90B
PE:20.44
High:140.27
Open:138.61
Low:137.75
Close:139.77
52wk High:157.29
52wk Low:93.37
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.72
T/O Rate:0.28%
Dividend:3.16
Dividend Rate:2.28%
EPS(TTM):6.78
EPS(LYR):6.78
ROE:40.66%
ROA:12.52%
PB:7.57
PE(LYR):20.44

Loading ...

Assessing Gilead Sciences (GILD) Valuation After Its Strong Multi Year Share Price Run

Simply Wall St.
·
Apr 06

Trump Will Impose 100% Tariff on Some Patented Drugs

Tiger Newspress
·
Apr 03

LIVE MARKETS-Big pharma goes on a shopping spree

Reuters
·
Apr 02

FDA grants full approval for Gilead unit Kite’s Tecartus in relapsed mantle cell lymphoma

Reuters
·
Apr 02

Gilead extends tender offer to acquire Arcellx

TIPRANKS
·
Apr 02

Gilead extends Arcellx tender offer deadline to April 24

Reuters
·
Apr 02

Gilead Extends Tender Offer to Acquire Arcellx

THOMSON REUTERS
·
Apr 02

Gilead - Tender Offer Expiration Extended to 5:00 P.m. Et on April 24, 2026

THOMSON REUTERS
·
Apr 02

Gilead - Offer Price $115 per Share Plus $5 CVR Payable March 31, 2030, IF Sales Milestone Met

THOMSON REUTERS
·
Apr 02

Gilead Sciences Inc Stock (GILD) Moved Up by 3.03% on Apr 1: Facts Behind the Movement

TradingKey
·
Apr 01

Gilead Sciences Shows Solid Early Yeztugo Persistence but Limited Market Expansion, RBC Says

MT Newswires Live
·
Mar 31

Gilead Sciences Inc Stock (GILD) Moved Up by 3.62% on Mar 31: A Full Analysis

TradingKey
·
Mar 31

Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves

TIPRANKS
·
Mar 31

Analysts Are Neutral on Top Healthcare Stocks: Gilead Sciences (GILD), United Therapeutics (UTHR)

TIPRANKS
·
Mar 31

Galapagos, Gilead enter pact to collaborate on T cell engager therapies

TIPRANKS
·
Mar 31

BRIEF-Galapagos, Gilead Enter Binding Agreement On Ouro Medicines Acquisition

Reuters
·
Mar 31

Galapagos, Gilead sign deal tied to Ouro acquisition for T cell engager program

Reuters
·
Mar 31

Galapagos Nv - Enters Binding Agreement With Gilead on Ouro Medicines Acquisition

THOMSON REUTERS
·
Mar 31

Galapagos Nv - to Fund 50% of $1.675 Bln Upfront and 50% of Milestone Payments for Ouro Deal

THOMSON REUTERS
·
Mar 31

Galapagos Nv - May Spend $500 Mln Independently, Including up to $150 Mln for Share Repurchases or Dividends

THOMSON REUTERS
·
Mar 31